| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $60.9M | +28.4% |
| SG&A Expense | $27.9M | +30.3% |
| Operating Income | -$88.9M | -29.0% |
| Income Tax | $0 | — |
| Net Income | -$82.6M | -21.0% |
| EPS (Basic) | -$2.13 | +1.4% |
| EPS (Diluted) | -$2.13 | +1.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $52.0M | -72.1% |
| Short-term Investments | $65.9M | — |
| Current Assets | $121.9M | -38.4% |
| Total Assets | $140.9M | -29.7% |
| Current Liabilities | $11.7M | +3.1% |
| Total Liabilities | $24.6M | +117.5% |
| Stockholders' Equity | $116.3M | -38.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$70.4M | -8.0% |
| Capital Expenditures | $674K | -26.8% |
| Investing Cash Flow | -$65.1M | -6972.5% |
| Financing Cash Flow | $888K | -99.4% |
| Free Cash Flow | -$71.0M | -7.5% |